ストックスクリーナーアプリを入手
15.62
0.22%
-0.02
前日終値:
$15.60
開ける：
$15.52
24時間の取引高:
635.84K
Relative Volume:
0.20
時価総額：
$4.03B
収益：
$6.41B
当期純損益:
$1.30B
株価収益率:
3.0992
EPS:
5.04
ネットキャッシュフロー:
$646.00M
1週間 パフォーマンス:
+1.67%
1か月 パフォーマンス:
+0.48%
6か月 パフォーマンス:
-20.14%
1年 パフォーマンス:
-14.95%
1日の値動き範囲:
$15.45
$15.65
1週間の範囲:
$15.30
$15.88
52週間の値動き範囲:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
OGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.62 | 4.03B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
841.61 | 754.10B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
210.01 | 374.57B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
76.93 | 338.61B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
163.46 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
93.41 | 238.10B | 64.17B | 17.12B | 18.10B | 6.73 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN
Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha
Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey
Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World
Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World
Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com
Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
Trend Tracker for (OGN) - Stock Traders Daily
Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World
Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace
MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow
Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks
Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan
Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune
Organon and partners drive innovation to strengthen healthcare access - Bangkok Post
Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World
Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
(OGN) Long Term Investment Analysis - Stock Traders Daily
Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat
A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey
Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World
Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World
The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net
Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
Savant Capital LLC Sells 88,315 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges - MSN
Organon announces departure of chief commercial officer - MSN
Philip James Wealth Mangement LLC Has $12.99 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
1.99%
大文字化:
|
ボリューム (24 時間):